{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:01:58Z","timestamp":1795118518505,"version":"4.10.3"},"reference-count":51,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UZH Global Strategy and Partnerships Funding Scheme, \u00abA bi-center interdisciplinary study investigating the first successful oral treatment of fatal coronavirus infection in cats\u00bb","award":["K-53420-02 01"],"award-info":[{"award-number":["K-53420-02 01"]}]},{"name":"UZH Global Strategy and Partnerships Funding Scheme, \u00abA bi-center interdisciplinary study investigating the first successful oral treatment of fatal coronavirus infection in cats\u00bb","award":["F-53130-44-01"],"award-info":[{"award-number":["F-53130-44-01"]}]},{"name":"UZH Global Strategy and Partnerships Funding Scheme, \u00abA bi-center interdisciplinary study investigating the first successful oral treatment of fatal coronavirus infection in cats\u00bb","award":["F-53130-45-01"],"award-info":[{"award-number":["F-53130-45-01"]}]},{"name":"UZH Global Strategy and Partnerships Funding Scheme, \u00abA bi-center interdisciplinary study investigating the first successful oral treatment of fatal coronavirus infection in cats\u00bb","award":["F-53420-10-01"],"award-info":[{"award-number":["F-53420-10-01"]}]},{"name":"UZH Scientific Research Grant, \u00abLong-term study of the effect and potential side effects of oral therapy with GS-441524 in cats with feline infectious peritonitis (FIP)\u00bb","award":["K-53420-02 01"],"award-info":[{"award-number":["K-53420-02 01"]}]},{"name":"UZH Scientific Research Grant, \u00abLong-term study of the effect and potential side effects of oral therapy with GS-441524 in cats with feline infectious peritonitis (FIP)\u00bb","award":["F-53130-44-01"],"award-info":[{"award-number":["F-53130-44-01"]}]},{"name":"UZH Scientific Research Grant, \u00abLong-term study of the effect and potential side effects of oral therapy with GS-441524 in cats with feline infectious peritonitis (FIP)\u00bb","award":["F-53130-45-01"],"award-info":[{"award-number":["F-53130-45-01"]}]},{"name":"UZH Scientific Research Grant, \u00abLong-term study of the effect and potential side effects of oral therapy with GS-441524 in cats with feline infectious peritonitis (FIP)\u00bb","award":["F-53420-10-01"],"award-info":[{"award-number":["F-53420-10-01"]}]},{"name":"Small Animal Foundation, Vetsuisse Faculty, University of Zurich","award":["K-53420-02 01"],"award-info":[{"award-number":["K-53420-02 01"]}]},{"name":"Small Animal Foundation, Vetsuisse Faculty, University of Zurich","award":["F-53130-44-01"],"award-info":[{"award-number":["F-53130-44-01"]}]},{"name":"Small Animal Foundation, Vetsuisse Faculty, University of Zurich","award":["F-53130-45-01"],"award-info":[{"award-number":["F-53130-45-01"]}]},{"name":"Small Animal Foundation, Vetsuisse Faculty, University of Zurich","award":["F-53420-10-01"],"award-info":[{"award-number":["F-53420-10-01"]}]},{"name":"Swiss Association for Small Animal Medicine","award":["K-53420-02 01"],"award-info":[{"award-number":["K-53420-02 01"]}]},{"name":"Swiss Association for Small Animal Medicine","award":["F-53130-44-01"],"award-info":[{"award-number":["F-53130-44-01"]}]},{"name":"Swiss Association for Small Animal Medicine","award":["F-53130-45-01"],"award-info":[{"award-number":["F-53130-45-01"]}]},{"name":"Swiss Association for Small Animal Medicine","award":["F-53420-10-01"],"award-info":[{"award-number":["F-53420-10-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The nucleoside analogue GS-441524 is a common treatment for cats with feline infectious peritonitis (FIP). In a previous study, 40 cats with FIP with effusion were treated with 15 mg\/kg GS-441524 orally once daily for either 42 days or 84 days, and a 42-day treatment was as effective as the earlier recommended 84-day treatment. The aim of the present study was to describe unexpected clinical and laboratory observations occurring during and after treatment (within one year) in these cats and to compare them regarding the different treatment durations. Thirty-eight cats recovered rapidly during treatment, two cats had to be euthanized, and one cat was lost to follow-up. During treatment, 25 cats developed diarrhea. Lymphocytosis occurred in 26\/40 cats during treatment, eosinophilia in 25\/40 during treatment, increased alanine aminotransferase activity in 22\/40, alkaline phosphatase activity in 7\/40, and symmetric dimethylarginine levels in 25\/40. These unexpected observations occurred equally in both treatment duration groups, but statistically significantly more cats developed lymphocytosis and eosinophilia when treated for 84 days. Although most of the unexpected observations during GS-441524 treatment improved or disappeared after treatment termination, these conditions have to be monitored, and treatment should not be given for longer than necessary.<\/jats:p>","DOI":"10.3390\/v17091181","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T12:25:57Z","timestamp":1756470357000},"page":"1181","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unexpected Clinical and Laboratory Observations During and After 42-Day Versus 84-Day Treatment with Oral GS-441524 in Cats with Feline Infectious Peritonitis with Effusion"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8344-2994","authenticated-orcid":false,"given":"Katharina","family":"Buchta","sequence":"first","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9288-3599","authenticated-orcid":false,"given":"Anna-Maria","family":"Zuzzi-Krebitz","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Bergmann","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-5411","authenticated-orcid":false,"given":"Roswitha","family":"Dorsch","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0470-776X","authenticated-orcid":false,"given":"Katharina","family":"Zwicklbauer","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Matiasek","sequence":"additional","affiliation":[{"name":"Institute of Veterinary Pathology, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-4296","authenticated-orcid":false,"given":"Regina","family":"Hofmann-Lehmann","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-2416","authenticated-orcid":false,"given":"Marina L.","family":"Meli","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-8256","authenticated-orcid":false,"given":"Andrea M.","family":"Spiri","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-4089","authenticated-orcid":false,"given":"Yury","family":"Zablotski","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Alberer","sequence":"additional","affiliation":[{"name":"Division of Paediatric Infectious Diseases, Dr. von Hauner Children\u2019s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-1071","authenticated-orcid":false,"given":"Ulrich","family":"von Both","sequence":"additional","affiliation":[{"name":"Division of Paediatric Infectious Diseases, Dr. von Hauner Children\u2019s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany"},{"name":"German Center for Infection Research (DZIF), Partner Site Munich, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-863X","authenticated-orcid":false,"given":"Katrin","family":"Hartmann","sequence":"additional","affiliation":[{"name":"LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/vr.129.10.209","article-title":"Feline infectious peritonitis: A review of clinicopathological changes in 65 cases, and a critical assessment of their diagnostic value","volume":"129","author":"Sparkes","year":"1991","journal-title":"Vet. Rec."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J. Feline Med. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100128","DOI":"10.1016\/j.onehlt.2020.100128","article-title":"Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses","volume":"9","author":"Amirian","year":"2020","journal-title":"One Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Krentz, D., Zenger, K., Alberer, M., Felten, S., Bergmann, M., Dorsch, R., Matiasek, K., Kolberg, L., Hofmann-Lehmann, R., and Meli, M.L. (2021). Curing cats with feline infectious peritonitis with an oral multi-component drug containing GS-441524. Viruses, 13.","DOI":"10.3390\/v13112228"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1098612X231183250","DOI":"10.1177\/1098612X231183250","article-title":"Long-term follow-up of cats in complete remission after treatment of feline infectious peritonitis with oral GS-441524","volume":"25","author":"Zwicklbauer","year":"2023","journal-title":"J. Feline Med. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zuzzi-Krebitz, A.M., Buchta, K., Bergmann, M., Krentz, D., Zwicklbauer, K., Dorsch, R., Wess, G., Fischer, A., Matiasek, K., and H\u00f6nl, A. (2024). Short treatment of 42 days with oral GS-441524 results in equal efficacy as the recommended 84-day treatment in cats suffering from feline infectious peritonitis with effusion\u2014A prospective randomized controlled study. Viruses, 16.","DOI":"10.3390\/v16071144"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Krentz, D., Zwicklbauer, K., Felten, S., Bergmann, M., Dorsch, R., Hofmann-Lehmann, R., Meli, M.L., Spiri, A.M., von Both, U., and Alberer, M. (2022). Clinical follow-up and postmortem findings in a cat that was cured of feline infectious peritonitis with an oral antiviral drug containing GS-441524. Viruses, 14.","DOI":"10.3390\/v14092040"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Addie, D.D., Covell-Ritchie, J., Jarrett, O., and Fosbery, M. (2020). Rapid resolution of non-effusive feline infectious peritonitis uveitis with an oral adenosine nucleoside analogue and feline interferon omega. Viruses, 12.","DOI":"10.3390\/v12111216"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jvim.15780","article-title":"Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis","volume":"34","author":"Dickinson","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jones, S., Novicoff, W., Nadeau, J., and Evans, S. (2021). Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals, 11.","DOI":"10.3390\/ani11082257"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Katayama, M., and Uemura, Y. (2021). Therapeutic effects of mutian(\u00ae) Xraphconn on 141 client-owned cats with feline infectious peritonitis predicted by total bilirubin levels. Vet. Sci., 8.","DOI":"10.3390\/vetsci8120328"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lv, J., Bai, Y., Wang, Y., Yang, L., Jin, Y., and Dong, J. (2022). Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.1002488"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jvim.16804","article-title":"Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524","volume":"37","author":"Green","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yin, Y., Li, T., Wang, C., Liu, X., Ouyang, H., Ji, W., Liu, J., Liao, X., Li, J., and Hu, C. (2021). A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-84754-0"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1098612x231194460","DOI":"10.1177\/1098612X231194460","article-title":"Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020\u20132022)","volume":"25","author":"Taylor","year":"2023","journal-title":"J. Feline Med. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jvim.16803","article-title":"Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524","volume":"37","author":"Coggins","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cosaro, E., Pires, J., Castillo, D., Murphy, B.G., and Reagan, K.L. (2023). Efficacy of oral remdesivir compared to gs-441524 for treatment of cats with naturally occurring effusive feline infectious peritonitis: A blinded, non-inferiority study. Viruses, 15.","DOI":"10.3390\/v15081680"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Addie, D.D., Silveira, C., Aston, C., Brauckmann, P., Covell-Ritchie, J., Felstead, C., Fosbery, M., Gibbins, C., Macaulay, K., and McMurrough, J. (2022). Alpha-1 acid glycoprotein reduction differentiated recovery from remission in a small cohort of cats treated for feline infectious peritonitis. Viruses, 14.","DOI":"10.21203\/rs.3.rs-1145695\/v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jvim.16954","article-title":"Uroliths composed of antiviral compound gs-441524 in 2 cats undergoing treatment for feline infectious peritonitis","volume":"38","author":"Allinder","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_21","first-page":"95","article-title":"Karnofsky\u2019s score modified for cats","volume":"3","author":"Hartmann","year":"1998","journal-title":"Eur. J. Med. Res."},{"key":"ref_22","unstructured":"(2025, August 20). Purina Fecal Scoring Chart. Available online: https:\/\/vetcentre.purina.co.uk\/sites\/default\/files\/2021-11\/Faecal%20scoring%20chart_general%20use.pdf."},{"key":"ref_23","unstructured":"(2024, July 25). Iris Staging of CKD. Available online: http:\/\/www.iris-kidney.com\/pdf\/2_IRIS_Staging_of_CKD_2023.pdf."},{"key":"ref_24","unstructured":"(2024, July 25). Diagnosing, Staging, and Treating Chronic Kidney Disease in Dogs and Cats. Available online: http:\/\/www.iris-kidney.com\/pdf\/IRIS_Pocket_Guide_to_CKD_2023.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/1098612X20941786","article-title":"Feline abdominal ultrasonography: What\u2019s normal? What\u2019s abnormal? renal pelvis, ureters and urinary bladder","volume":"22","author":"Griffin","year":"2020","journal-title":"J. Feline Med. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1128\/jvi.70.12.8977-8983.1996","article-title":"Apoptosis and t-cell depletion during feline infectious peritonitis","volume":"70","author":"Haagmans","year":"1996","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vetmic.2006.08.033","article-title":"A \u201cpossible\u201d involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis","volume":"119","author":"Takano","year":"2007","journal-title":"Vet. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2003.08.010","article-title":"In vivo cytokine response to experimental feline infectious peritonitis virus infection","volume":"97","author":"Dean","year":"2003","journal-title":"Vet. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cianci, R., Massaro, M.G., De Santis, E., Totti, B., Gasbarrini, A., Gambassi, G., and Giambra, V. (2023). Changes in lymphocyte subpopulations after remdesivir therapy for COVID-19: A brief report. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914973"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yan, Y., Li, J., Jiao, Z., Yang, M., Li, L., Wang, G., Chen, Y., Li, M., Shen, Z., and Shi, Y. (2023). Better therapeutic effect of oral administration of GS441524 compared with GC376. Vet. Microbiol., 283.","DOI":"10.1016\/j.vetmic.2023.109781"},{"key":"ref_31","first-page":"3596","article-title":"Characterization of the lymphocyte response in cats with feline infectious peritonitis during antiviral treatment using the smart tube technology for flow cytometry in feline full blood samples","volume":"38","author":"Zwicklbauer","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zwicklbauer, K., von la Roche, D., Krentz, D., Kolberg, L., Alberer, M., Zablotski, Y., Hartmann, K., von Both, U., and H\u00e4rtle, S. (2024). Adapting the smart tube technology for flow cytometry in feline full blood samples. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1377414"},{"key":"ref_33","first-page":"V06","article-title":"Ein-Jahres-Follow-Up von Katzen nach Therapie der felinen infekti\u00f6sen Peritonitis mit oralem GS-441524 f\u00fcr 42 versus 84 Tage","volume":"53","author":"Buchta","year":"2025","journal-title":"Tier\u00e4rztliche Prax. Ausg. K Kleintiere\/Heimtiere"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Mateos Gonz\u00e1lez, M., Sierra Gonzalo, E., Casado Lopez, I., Arnalich Fern\u00e1ndez, F., Beato P\u00e9rez, J.L., Monge Monge, D., Vargas N\u00fa\u00f1ez, J.A., Garc\u00eda Fenoll, R., Su\u00e1rez Fern\u00e1ndez, C., and Freire Castro, S.J. (2021). The prognostic value of eosinophil recovery in COVID-19: A multicentre, retrospective cohort study on patients hospitalised in spanish hospitals. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020305"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1182\/blood-2015-04-640623","article-title":"Mechanism of enhanced eosinophil survival in inflammation","volume":"125","author":"Zimmermann","year":"2015","journal-title":"Blood"},{"key":"ref_36","first-page":"71","article-title":"Drug-induced eosinophilia","volume":"264","author":"Ian","year":"2000","journal-title":"Pharm. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.aivir.2016.08.002","article-title":"Feline coronaviruses: Pathogenesis of feline infectious peritonitis","volume":"96","author":"Tekes","year":"2016","journal-title":"Adv. Virus. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcpa.2024.10.003","article-title":"Anatomopathological characterization of hepatic lesions of feline infectious peritonitis in cats","volume":"215","author":"Cony","year":"2024","journal-title":"J. Comp. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Malbon, A.J., Fonfara, S., Meli, M.L., Hahn, S., Egberink, H., and Kipar, A. (2019). Feline infectious peritonitis as a systemic inflammatory disease: Contribution of liver and heart to the pathogenesis. Viruses, 11.","DOI":"10.3390\/v11121144"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.apsb.2021.03.028","article-title":"Can remdesivir and its parent nucleoside gs-441524 be potential oral drugs? an in vitro and in vivo dmpk assessment","volume":"11","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12072-020-10077-3","article-title":"Liver injury in remdesivir-treated COVID-19 patients","volume":"14","author":"Zampino","year":"2020","journal-title":"Hepatol. Int."},{"key":"ref_42","unstructured":"Kramer, J.W., Hoffman, W.E., Kaneko, J.J., Harvey, J.W., and Bruss, M.L. (1997). Clinical Enzymology, Academic Press."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2460\/javma.228.7.1033","article-title":"Effect of age on reference intervals of serum biochemical values in kittens","volume":"228","author":"Levy","year":"2006","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jvim.12445","article-title":"Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease","volume":"28","author":"Hall","year":"2014","journal-title":"J. Vet. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/1098612X20983260","article-title":"Comparison of serum and plasma SDMA measured with point-of-care and reference laboratory analysers: Implications for interpretation of SDMA in cats","volume":"23","author":"Baral","year":"2021","journal-title":"J. Feline Med. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jsap.13236","article-title":"The new age of renal biomarkers: Does sdma solve all of our problems?","volume":"62","author":"Sargent","year":"2021","journal-title":"J. Small Anim. Pract."},{"key":"ref_47","first-page":"631","article-title":"Proteinuria in dogs and cats","volume":"53","author":"Harley","year":"2012","journal-title":"Can. Vet. J."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Furbish, A., Allinder, M., Austin, G., Tynan, B., Byrd, E., and Gomez, I.P. (2024). Peterson. First analytical confirmation of drug-induced crystal nephropathy in felines caused by GS-441524, the active metabolite of remdesivir. J. Pharm. Biomed. Anal., 247.","DOI":"10.1016\/j.jpba.2024.116248"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2460\/javma.23.08.0466","article-title":"Unlicensed antiviral products used for the at-home treatment of feline infectious peritonitis contain GS-441524 at significantly different amounts than advertised","volume":"262","author":"Kent","year":"2024","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gtc.2022.11.001","article-title":"Diarrhea and coronavirus disease 2019 infection","volume":"52","author":"Friedel","year":"2023","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wu, Y., Cheng, X., Jiang, G., Tang, H., Ming, S., Tang, L., Lu, J., Guo, C., Shan, H., and Huang, X. (2021). Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes, 7.","DOI":"10.1038\/s41522-021-00232-5"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1181\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:10Z","timestamp":1760034910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["v17091181"],"URL":"https:\/\/doi.org\/10.3390\/v17091181","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}